These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 4589709)
1. Fenfluramine in corticosteroid-induced obesity. Cameron DC; Kennedy WP; Samuel PD; Crompton GK Curr Med Res Opin; 1972; 1(3):153-8. PubMed ID: 4589709 [No Abstract] [Full Text] [Related]
2. Anorectic effectiveness of differing dosage forms of fenfluramine. Tisdale SA; Ervin DK Curr Ther Res Clin Exp; 1976 Jun; 19(6):589-94. PubMed ID: 819218 [No Abstract] [Full Text] [Related]
3. Treatment of obesity with fenfluramine. Persson I; Andersen U; Deckert T Eur J Clin Pharmacol; 1973 Aug; 6(2):93-7. PubMed ID: 4588854 [No Abstract] [Full Text] [Related]
4. [The effect of Ponderal in patients with refractory overweight]. Myking O; Bassoe HH; Closs K Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2541-5. PubMed ID: 4589597 [No Abstract] [Full Text] [Related]
5. Fenfluramine in the treatment of obesity. Stunkard A; Rickels K; Hesbacher P Lancet; 1973 Mar; 1(7802):503-5. PubMed ID: 4119946 [No Abstract] [Full Text] [Related]
6. [Treatment of obesity with fenfluramine (Ponderal)]. Persson I; Andersen UD; Deckert T Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075 [No Abstract] [Full Text] [Related]
7. A double-blind clinical trial of fenfluramine in the treatment of obesity. Sainani GS; Fulambarkar AM; Khurana BK Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636 [No Abstract] [Full Text] [Related]
8. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study]. Haug E; Myklebust R Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598 [No Abstract] [Full Text] [Related]
10. Circulatory effects of fenfluramine in obese hypertensive patients. Mroczek WJ; Lee WR; Finnerty FA Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654 [No Abstract] [Full Text] [Related]
11. A clinical trial of a new fenfluramine preparation (Ponderax PA). Hooper AC Postgrad Med J; 1975; 51 Suppl 1():159-60. PubMed ID: 768960 [No Abstract] [Full Text] [Related]
12. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties. Elliott BW Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837 [No Abstract] [Full Text] [Related]
13. Prolonged action fenfluramine capsules versus fenfluramine tablets in general practice. Maneksha S Br J Clin Pract; 1975 Jan; 29(1):12-13. PubMed ID: 1095042 [No Abstract] [Full Text] [Related]
14. A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules. Innes JA; Campbell IW; Millar J; Munro JF Postgrad Med J; 1975; 51 Suppl 1():160-2. PubMed ID: 768961 [No Abstract] [Full Text] [Related]
15. Fenfluramine in the management of obesity. Datey KK; Kelkar PN; Pandya RS Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613 [No Abstract] [Full Text] [Related]
16. A controlled investigation of the "glycolyptic" action of fenfluramine. Garrow JS; Belton EA; Daniels A Lancet; 1972 Sep; 2(7777):559-61. PubMed ID: 4115737 [No Abstract] [Full Text] [Related]
17. Treatment of obesity with fenfluramine. Schindler H; Bielesz G Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579 [No Abstract] [Full Text] [Related]
18. A double-blind clinical trial of fenfluramine. Lele RD; Joshi VR; Nathwani AN Br J Clin Pract; 1972 Feb; 26(2):79-82. PubMed ID: 4552745 [No Abstract] [Full Text] [Related]
19. Evaluation of three anorexiants. Clortermine hydrochloride (voranil), fenfluramine hydrochloride (pondimin), and mazindol (sanorex). Dykes MH JAMA; 1974 Oct; 230(2):270-2. PubMed ID: 4606535 [No Abstract] [Full Text] [Related]